CD4+ T Cells Promote Vγ9Vδ2 T Cell Expansion and Anti-Mycobacterial Function via IL-2

Technical Summary: CD4+ T Cells Promote Vγ9Vδ2 T Cell Expansion and Anti-Mycobacterial Function via IL-2

Problem Statement
Tuberculosis (TB) remains a leading cause of infectious disease mortality globally, a burden exacerbated by HIV co-infection which depletes CD4+ T cells. While Vγ9Vδ2 T cells are critical for early anti-mycobacterial immunity through the recognition of phosphoantigens like (E)-4-hydroxy-3-methyl-but-2-enyl pyrophosphate (HMBPP), the magnitude of their expansion and effector response varies significantly between individuals. The mechanisms underlying this heterogeneity and the specific role of CD4+ T cells in regulating Vγ9Vδ2 T cell responses, particularly in the context of CD4+ lymphopenia (e.g., HIV), remain poorly understood.

Methodology
The study employed a multi-faceted approach using peripheral blood mononuclear cells (PBMCs) from healthy donors and HIV-infected individuals:

• Stratification: Healthy donors were classified as "high responders" (HR) or "low responders" (LR) based on the proliferative capacity of their Vγ9Vδ2 T cells following HMBPP stimulation.
• Correlation Analysis: The study analyzed the correlation between CD4+ T cell abundance (frequency and absolute count) and Vγ9Vδ2 T cell expansion.
• Depletion Models: A CD4+ T cell-depleted model (PBMC ΔCD4) was established using magnetic-activated cell sorting to isolate the specific contribution of CD4+ T cells.
• Rescue Experiments: The functional impact of CD4+ deficiency was assessed by supplementing cultures with exogenous recombinant human IL-2 (hIL-2).
• Functional Assays:
  • Cytokine Production: Intracellular flow cytometry was used to measure IL-2 production by CD4+ T cells and IFN-γ/TNF-α production by Vγ9Vδ2 T cells at 3 and 7 days post-stimulation.
  • Gene Expression: qRT-PCR quantified IL2 mRNA levels.
  • Anti-Mycobacterial Activity: An intracellular killing assay was performed using BCG-infected THP-1 macrophages, with bacterial burden quantified via colony-forming unit (CFU) enumeration.
• Clinical Cohort: PBMCs from HIV-infected individuals with known CD4+ lymphopenia were utilized to validate findings in a pathological context.

Key Results

• CD4+ Abundance Correlates with Response: HR donors exhibited significantly higher frequencies and absolute numbers of CD4+ T cells compared to LR donors. A strong positive correlation was found between CD4+ T cell abundance and Vγ9Vδ2 T cell expansion, whereas correlations with CD8+ or total CD3+ T cells were weak.
• IL-2 Production: HMBPP stimulation significantly upregulated IL-2 production in CD4+ T cells. HR donors demonstrated a more robust induction of IL-2 compared to LR donors.
• Dependency on CD4+ Cells: Depletion of CD4+ T cells (PBMC ΔCD4) profoundly impaired HMBPP-induced Vγ9Vδ2 T cell proliferation, IFN-γ/TNF-α production, and intracellular killing of BCG.
• Partial Rescue by IL-2: Supplementation with exogenous IL-2 partially restored Vγ9Vδ2 T cell proliferation and effector functions in CD4+ deficient conditions. However, the recovery was incomplete compared to CD4-sufficient controls, suggesting CD4+ T cells provide additional signals beyond IL-2.
• HIV Context: Vγ9Vδ2 T cells from HIV-infected donors with low CD4+ counts showed severely impaired proliferative responses to HMBPP, which were significantly rescued by exogenous IL-2, though not fully restored to healthy levels.

Key Contributions

• Mechanistic Insight: The study identifies CD4+ T cell-derived IL-2 as a critical mediator required for optimal HMBPP-induced expansion and effector function of Vγ9Vδ2 T cells.
• Explanation of Heterogeneity: It provides a cellular basis for the interindividual variability in Vγ9Vδ2 T cell responses, linking robust expansion to the abundance and IL-2-producing capacity of CD4+ T cells.
• Pathological Relevance: The research characterizes the functional deficit of Vγ9Vδ2 T cells in the setting of CD4+ lymphopenia (HIV), demonstrating that this impairment is at least partially reversible with IL-2 supplementation.

Significance and Claims
The authors claim that their findings delineate a previously underappreciated mechanism where CD4+ T cells regulate innate-like Vγ9Vδ2 T cell immunity through an IL-2-dependent manner. The study suggests that while phosphoantigen signaling (HMBPP) is necessary, it is insufficient for maximal Vγ9Vδ2 T cell responses without CD4+ T cell help.

The paper posits that these insights offer new perspectives for host-directed immunotherapeutic strategies for tuberculosis, particularly for HIV-associated TB where CD4+ T cell depletion compromises the anti-mycobacterial capacity of Vγ9Vδ2 T cells. The authors emphasize that while exogenous IL-2 can partially rescue these defects, the incomplete restoration of function in CD4+ deficient models indicates that CD4+ T cells likely provide additional essential signals or a sustained microenvironmental context necessary for optimal immunity.